Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
977
Sort by:
Global DTaP Vaccine Market - 2025-2033
US$ 4,350.00
Global DTaP Vaccine Market – Industry Trends & Outlook The global DTaP vaccine market reached US$ 5,378.83 Million in 2024 and is expected to reach US$ 11,592.17 Million by 2033, growing at a CAGR of...
May 2025
180 pages
Global MRNA Vaccines and Therapeutics Market - 2025-2033
US$ 4,350.00
Global MRNA Vaccines and Therapeutics Market Size - Industry Trends & Outlook The global MRNA Vaccines and Therapeutics market size reached US$ 410 Million in 2024 and is expected to reach US$ 850.90...
May 2025
168 pages
Global Travelers Vaccines Market - 2025-2033
US$ 4,350.00
Global Travelers Vaccines Market - Industry Outlook & Trends The global traveler's vaccines market reached US$ 4,092.58 million in 2024 and is expected to reach US$ 9,054.68 million by 2033, growing a...
May 2025
180 pages
Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Infection (COVID-19, Influenza), By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Respiratory Disease Vaccine Market Growth & Trends The respiratory disease vaccine market size is estimated to reach USD 70.30 bill...
May 2025
100 pages
Meningococcal Vaccines Market - 2025-2033
US$ 3,400.00
Meningococcal Vaccines Marketis is growing with a CAGR of 6.40% during the forecast period 2026-2035. The Meningococcal Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth ana...
May 2025
48 pages
Human Papillomavirus Vaccines Market Size, Share & Trends Analysis Report By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Anal Cancer), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Human Papillomavirus Vaccines Market Growth & Trends The global Human Papillomavirus vaccines market size is expected to reach USD...
May 2025
195 pages
DTaP Vaccine Market - 2025-2033
US$ 3,400.00
DTaP Vaccine Marketis is growing with a CAGR of 8.90% during the forecast period 2026-2035. The DTaP Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasone...
May 2025
38 pages
Human Papillomavirus (HPV) Vaccines Market - 2025-2033
US$ 3,400.00
Human Papillomavirus (HPV) Vaccines Marketis is growing with a CAGR of 16.90% during the forecast period 2026-2035. The Human Papillomavirus (HPV) Vaccines Market emerges as a key focus in DataM Intel...
May 2025
61 pages
Travelers Vaccines Market - 2025-2033
US$ 3,400.00
Travelers Vaccines Marketis is growing with a CAGR of 8.70% during the forecast period 2026-2035. The Travelers Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
May 2025
44 pages
Global Influenza Market – Vaccines and Therapeutics
US$ 4,500.00
... a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining ... analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe ...
April 2025
387 pages
Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2025-2033
US$ 2,999.00
The global vaccine market size reached USD 59.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 136.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.12% during 202...
April 2025
144 pages
Saudi Arabia Influenza Vaccine Market By Vaccine Type (Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine), By Distribution Channel (Hospital, Retail Pharmacies, Government Suppliers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Saudi Arabia Influenza Vaccine Market was valued at USD 44.26 Million in 2024 and is expected to reach USD 53.81 Million by 2030 with a CAGR of 3.51% during the forecast period. The vaccine available...
January 2025
85 pages
Influenza Vaccines Market, Persons Vaccinated, By Segment – Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)
US$ 2,690.00
The global influenza vaccines market is projected to reach US$ 12.16 Billion by 2032, from US$ 7.60 Billion in 2024. Influenza is a highly communicable disease and typically has the most severe impact...
January 2025
388 pages
Tetanus Toxoid Vaccine Market Size, Share & Trends Analysis Report By Vaccine (Diphtheria, Tetanus, And Pertussis (DTaP)), By Disease (Tetanus, Diphtheria), By End Use (Hospital, Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Tetanus Toxoid Vaccine Market Growth & Trends The global tetanus toxoid vaccine market size is anticipated t%li%reach USD 8.09 bill...
January 2025
153 pages
Vaccines Market Size, Share, and Analysis, By Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, and mRNA), By Type (Monovalent and Multivalent), By Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, and RSV), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Vaccines Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 66.4 billion and is proj...
December 2024
560 pages
Human Anti-rabies Vaccine Market - 2024-2031
US$ 3,400.00
Human Anti-rabies Vaccine Marketis is growing with a CAGR of 5.70% during the forecast period 2026-2035. The Human Anti-rabies Vaccine Market emerges as a key focus in DataM Intelligence latest in-dep...
August 2024
51 pages
H1N1 (swine flu) Vaccination Market - 2024-2031
US$ 3,400.00
The H1N1 (swine flu) Vaccination Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
July 2024
54 pages
Malaria Vaccines Market - 2024-2031
US$ 3,400.00
Malaria Vaccines Marketis is growing with a CAGR of 31.85% during the forecast period 2026-2035. The Malaria Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wher...
June 2024
42 pages
Anthrax Vaccines Market - 2024-2031
US$ 3,400.00
Anthrax Vaccines Marketis is growing with a CAGR of 7.40% during the forecast period 2026-2035. The Anthrax Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
June 2024
42 pages
Foot and Mouth Disease Vaccines Market - 2024-2031
US$ 3,400.00
Foot and Mouth Disease Vaccines Marketis is growing with a CAGR of 8.60% during the forecast period 2026-2035. The Foot and Mouth Disease Vaccines Market emerges as a key focus in DataM Intelligence l...
June 2024
57 pages
Age Related Vaccine Adjuvant Market - 2024-2031
US$ 3,400.00
Age Related Vaccine Adjuvant Marketis is growing with a CAGR of 10.60% during the forecast period 2026-2035. The Age Related Vaccine Adjuvant Market emerges as a key focus in DataM Intelligence latest...
May 2024
54 pages
Pertussis Vaccine Market - 2024-2031
US$ 3,400.00
Pertussis Vaccine Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Pertussis Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
March 2024
43 pages
Viral Vector Vaccines Market - 2024-2031
US$ 3,400.00
Viral Vector Vaccines Marketis is growing with a CAGR of 14.00% during the forecast period 2026-2035. The Viral Vector Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth anal...
February 2024
47 pages
Global Markets for Vaccine Technologies
US$ 4,650.00
... tables An overview of the global market for vaccine technologies Analyses of global market trends, with data from 2016 ... animals) and disease indications (infectious, cancer, and allergy) Examination of the industry environment, strategies, market influences, and driving forces Identification of regional market ...
January 2024
213 pages
Global Influenza Vaccines Market and Forecasts 2024 – 2032
US$ 3,500.00
The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period. Several factors ar...
January 2024
310 pages
Dendritic Cell Cancer Vaccines Market - 2024-2031
US$ 3,400.00
The Dendritic Cell Cancer Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2024
56 pages
Varicella Attenuated Live Vaccine Market - 2024-2031
US$ 3,400.00
Varicella Attenuated Live Vaccine Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Varicella Attenuated Live Vaccine Market emerges as a key focus in DataM Intelligen...
January 2024
59 pages
Meningitis Vaccines Market - 2024-2031
US$ 3,400.00
Meningitis Vaccines Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Meningitis Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
January 2024
45 pages
Therapeutic Vaccine Market - 2024-2031
US$ 3,400.00
The Therapeutic Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
January 2024
45 pages
Shigella Vaccines Pipeline Market - 2024-2031
US$ 3,400.00
The Shigella Vaccines Pipeline Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
November 2023
52 pages
Vaccine Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... by the big pharma and big biotech companies of the world in terms of deals made. One of the key highlights of the report is that over 450 online deals records of actual vaccine deals ...
November 2023
400 pages
Encephalitis Vaccines Market - 2024-2031
US$ 3,400.00
Encephalitis Vaccines Marketis is growing with a CAGR of 5.40% during the forecast period 2026-2035. The Encephalitis Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analy...
May 2023
47 pages
DNA Vaccines Market: By Type (Human DNA Vaccines and Animal DNA Vaccines), By End user (Infectious disease, Oncology, Allergies and Veterinary Diseases), By Distribution Channel (Hospital and retail pharmacies, Government suppliers), And Region – Global Analysis of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031
US$ 4,950.00
According to a recently published Fatpos Global study on 'DNA Vaccines Market,' the market is segmented by material type, thickness, application, transparency, end-use industry, and geography. The DNA...
March 2023
367 pages
Nasal Vaccines: Global Markets and Pipeline Analysis
US$ 5,500.00
Report : This report examines trends and sales in the global market for nasal vaccines through 2027. Leaders in the industry and their vaccine portfolios, the need for nasal vaccine development, compe...
December 2022
78 pages